02197 CLOVER BIO-B
Closed Add to Porfolio| Index Constituent : None | |||
| Major Shareholders | LIANG Peng (16.31%) Hillhouse Investment Management, Ltd. (12.14%) Shibi Wang & Family (6.98%) |
Sector | Health Care & Biotechnology |
|---|---|---|---|
| Web Site | http://www.cloverbiopharma.com | Tel | N/A |
| investors@cloverbiopharma.com | Fax | N/A | |
| Related Equities | N/A | ||
| Principal Activities | Principally engaged in the research and development of biopharmaceutical products. | ||
Consolidated List of Substantial Shareholders
| Name | Number of Shares Interested | % of Issued Share Capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Complete List of Directors
| Director's Name | Number of Shares Interested | % of issued share capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
